Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation
Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health Technology Assessment 2009; 13(11): 1-268
Authors' conclusions
Study found that the evidence for amantadine prophylaxis was limited but that oseltamivir and zanamivir were effective in preventing seasonal laboratory-confirmed influenza (SLCI) in a number of subgroups.
NETSCC, Health Technology Assessment, Alpha House, University of Southampton Science Park, Southampton, SO16 7NS UK Tel: +44 23 8059 5586 Email: hta@hta.ac.uk